Latest chemotherapy Stories
Researchers in Korea have published details of a mesothelioma patient who survived more than twice as long as the average after receiving a treatment combination including photodynamic therapy.
DUBLIN, Feb .11, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/ptgkrh/drug_delivery_in)
BCC Research (http://www.bccresearch.com) reveals in its new report on breast cancer diagnostic and drug technologies that many side effects,
Selective RORgamma agonist product candidates demonstrated activity as single agent therapy NEW YORK and ANN ARBOR, Mich., Feb.
LUGANO, Switzerland and SINGAPORE, February 9, 2015 /PRNewswire/ -- The exclusive agreement builds on our existing partnerships in the area of cancer supportive care across
TIANJIN, China, Feb.
Nation’s largest cancer magazine reports on beloved television host’s experiences, guidance for others. Plainsboro, NJ (PRWEB) February 05, 2015
LUGANO, Switzerland and COPENHAGEN, Denmark, February 5, 2015 /PRNewswire/ -- - Elsiglutide is a GLP-2 receptor agonist with potential as a first-ever therapy to help cancer
GOTHENBURG, Sweden, CAMBRIDGE, England and CLINTON, New Jersey, February 5, 2015 /PRNewswire/ -- Isofol (http://www.isofolmedical.com), a clinical stage pharmaceutical
LUGANO, Switzerland and MEXICO CITY, February 2, 2015 /PRNewswire/ -- The exclusive agreement strengthens the existing alliance between the companies in the area of supportive
Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...
Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.